Clinical trial
Phase 3: Analysis of a Beneficial Effect of Prolonges Topical Steroid Treatment After Low-risk Penetrating Keratoplasty
NCT00450996 is registered in ClinicalTrials.gov with University of Erlangen-Nürnberg Medical School as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 3: Analysis of a Beneficial Effect of Prolonges Topical Steroid Treatment After Low-risk Penetrating Keratoplasty
- Lead sponsor
- University of Erlangen-Nürnberg Medical School
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 1999
- Completion date
- March 31, 2007
- Enrollment
- 400
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
graft rejection